Abstract
Hemophagocytic Lymphohistiocytosis (HLH) in coronavirus disease 2019 (COVID-19) is a recognized complication of severe illness. However, this phenomenon has been reported most often in the setting of acute infection. Here we present a case of a patient with a history of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection that subsequently developed HLH weeks after treatment of COVID-19 and discharges from the hospital. Upon re-admission, work-up demonstrated the patient was experiencing Epstein-Barr virus (EBV) reactivation. As EBV infection is a known etiological trigger of HLH, this case provides an alternative mechanism for HLH seen in patients with a history of COVID-19 infection who present after the resolution of acute symptomatology.
Publisher
Peertechz Publications Private Limited
Reference11 articles.
1. 1. Allen J, McCambridge MM, Kincaid H, Kalter JA (2021) Incidence of Secondary Hemophagocytic Lymphohistiocytosis in Critically-Ill COVID-19 Patients. Cureus 13: e16735. Link: https://bit.ly/3gMl6jh
2. 2. Schnaubelt S, Tihanyi D, Strassl R, Schmidt R, Anders S, et al. (2021) Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach. Medicine (Baltimore) 100: e25170. Link: https://bit.ly/3I6Q7ut
3. 3. Paolucci S, Cassaniti I, Novazzi F, Fiorina L, Piralla A, et al. (2021) San Matteo Pavia COVID-19 Task Force. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis 104: 315-319. Link: https://bit.ly/36f8ejH
4. 4. Chen T, Song J, Liu H, Zheng H, Chen C (2021) Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep 11: 10902. Link: https://bit.ly/3LsLxsi
5. 5. Kleynberg RL, Schiller GJ (2012) Secondary hemophagocytic lymphohistiocytosis in adults: an update on diagnosis and therapy. Clin Adv Hematol Oncol 10: 726-732. Link: https://bit.ly/3oOCsQK
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献